Search clinical trials for: SAR443122

Total 10 results

Sanofi

Completed

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (CLEan)

Cutaneous Lupus Erythematosus

Chile, Italy, Czechia, Mexico, Spain, Ukraine, United States, Argentina, Australia, Canada, Hungary, India, Poland, Russian Federation, United Kingdom
Sanofi

Recruiting

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis (RESOLUTE)

Colitis Ulcerative

Argentina, Chile, United States, China, Czechia, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Spain, United Kingdom
Sanofi

Completed

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Corona Virus Infection

Mexico, Argentina, Brazil, Chile, Russian Federation
Sanofi

Completed

A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)

Amyotrophic Lateral Sclerosis (Healthy Volunteers)

United States
Sanofi

Completed

Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants

Amyotrophic Lateral Sclerosis (Healthy Volunteers)

United States
Sanofi

Terminated

Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors

Breast Cancer | Gastric Cancer | Neoplasm | Lung Neoplasm Malignant | Neoplasm Malignant

Belgium, Korea, Republic of, United States, Taiwan, Spain, France
Sanofi

Active, not recruiting

A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

Multiple Sclerosis

Belgium, Bulgaria, Canada, Chile, China, France, Germany, Italy, Poland, Spain
Sanofi

Terminated

Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) (HIMALAYA)

Amyotrophic Lateral Sclerosis

Netherlands, China, Poland, Italy, Belgium, United States, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
Sanofi

Completed

Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants

Multiple Sclerosis Healthy Subjects

United Kingdom
Sanofi

Completed

A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

Amyotrophic Lateral Sclerosis (Healthy Volunteers)

United States

3

Subscribe